Usman Choudhry, DO
Physical Medicine & Rehabilitation · Gainesville, GANPI 1215371380
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,558 of the $6,113 with a category attached, or 74.6%. It is spread thinly across 28 manufacturers, the largest accounting for just 20.2%.
Across 131 payments — averaging $46.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Boston Scientific$1K
- Curonix LLC$852
- Globus Medical$519
- Abbott$486
- Virtus Pharmaceuticals LLC$308
- plus $2K from 22 others
What the payments were for
- Travel & lodging$1,53625%
- Food & beverage$4,55875%
- Entertainment$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 7 | $1,235 |
| Boston Scientific | 31 | $1,207 |
| Curonix LLC | 9 | $852 |
| Globus Medical | 7 | $519 |
| Abbott | 9 | $486 |
| Virtus Pharmaceuticals LLC | 16 | $308 |
| Biotronik NRO, Inc. | 10 | $286 |
| GRT US Holding, Inc. | 1 | $210 |
| Averitas Pharma Inc. | 4 | $183 |
| Spinal Simplicity, LLC | 3 | $121 |
| Vertos Medical, Inc. | 3 | $101 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $96 |
| Vertex | 3 | $80 |
| SPR Therapeutics, Inc | 3 | $65 |
| Nevro Corp. | 2 | $64 |
| Si-bone, Inc. | 4 | $62 |
| Bioventus LLC | 1 | $34 |
| Protega Pharmaceutials Inc | 2 | $34 |
| Tersera Therapeutics LLC | 1 | $22 |
| Foundation Fusion Solutions, LLC | 1 | $19 |
| MML US, Inc. | 2 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Pfizer | 1 | $15 |
| Radius Health, Inc. | 1 | $15 |
| Valinor Pharma, LLC | 1 | $15 |
| Pacira Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,113 in reported general payments places this provider in the 85th percentile of 214 physical medicine & rehabilitation providers in Georgia.
See all physical medicine & rehabilitation providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,335 | $55,885 |
| OxycontinOxycodone Hcl | 37 | $34,636 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,167 | $29,714 |
| MovantikNaloxegol Oxalate | 46 | $22,946 |
| Fentanyl | 138 | $17,794 |
| Xtampza ErOxycodone Myristate | 31 | $14,559 |
| Oxycodone Hcl | 577 | $11,697 |
| Gabapentin | 887 | $11,327 |
| Pregabalin | 552 | $9,249 |
| Celecoxib | 351 | $7,900 |
| BelbucaBuprenorphine Hcl | 11 | $6,954 |
| Buprenorphine | 19 | $6,212 |
| Methocarbamol | 503 | $6,083 |
| Duloxetine Hcl | 342 | $4,594 |
| Morphine Sulfate ErMorphine Sulfate | 146 | $3,399 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $18 | $21,51342 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 214 physical medicine & rehabilitation providers in Georgia.
Other physical medicine & rehabilitation in Gainesville
- Erik ShawAtlanta$175K
- David TranAlpharetta$96K
- Payal FadiaDecatur$66K
- John MusserStockbridge$57K
- Abana AzariahAtlanta$22K
- Michael SchaufeleAtlanta$20K
- Gerald ChaiLawrenceville$16K
- Gerald BilskyAtlanta$16K
- Aiwane IboayaColumbus$16K
- Joseph HegartyBaxley$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.